seretide 50+500 mikrog./dosis inhalationspulver, afdelt
orifarm a/s - fluticasonpropionat, salmeterolxinafoat - inhalationspulver, afdelt - 50+500 mikrog./dosis
seretide 50+100 mikrog./dosis inhalationspulver, afdelt
orifarm a/s - fluticasonpropionat, salmeterolxinafoat - inhalationspulver, afdelt - 50+100 mikrog./dosis
airexar spiromax
teva b.v. - salmeterol, fluticasonpropionat - pulmonary disease, chronic obstructive; asthma - medicin for obstruktiv sygdomme, - airexar spiromax er indiceret til brug kun hos voksne i alderen 18 år og ældre. asthmaairexar spiromax is indicated for the regular treatment of patients with severe asthma where use of a combination product (inhaled corticosteroid and long-acting β2 agonist) is appropriate:- patients not adequately controlled on a lower strength corticosteroid combination productor- patients already controlled on a high dose inhaled corticosteroid and long-acting β2 agonist. kronisk obstruktiv lungesygdom (kol)airexar spiromax er indiceret til symptomatisk behandling af patienter med kol med fev1.
flurhin 50 mikrogram/dosis næsespray, suspension
2care4 generics aps - fluticasonpropionat - næsespray, suspension - 50 mikrogram/dosis
dymista 137+50 mikrog/dosis næsespray, suspension
viatris aps - azelastinhydrochlorid, fluticasonpropionat - næsespray, suspension - 137+50 mikrog/dosis
dymista 137+50 mikrog/dosis næsespray, suspension
orifarm a/s - azelastinhydrochlorid, fluticasonpropionat - næsespray, suspension - 137+50 mikrog/dosis
dymista 137+50 mikrog/dosis næsespray, suspension
2care4 aps - azelastinhydrochlorid, fluticasonpropionat - næsespray, suspension - 137+50 mikrog/dosis
dymista 137+50 mikrog/dosis næsespray, suspension
paranova danmark a/s - azelastinhydrochlorid, fluticasonpropionat - næsespray, suspension - 137+50 mikrog/dosis
flixonase 1 mg/ml næsedråber, suspension
haleon denmark aps - fluticasonpropionat - næsedråber, suspension - 1 mg/ml
flixonase 1 mg/ml næsedråber, suspension
orifarm a/s - fluticasonpropionat - næsedråber, suspension - 1 mg/ml